Here's Why You Should Hold Surmodics (SRDX) Stock for Now
Surmodics(SRDX) zacks.com·2024-05-20 23:50
Thrombectomy Prospects Bright: Surmodics' aim to leverage its proprietary Pounce thrombectomy platform technology to develop products raises our optimism. The company announced the completion of limited market evaluation and commercial launch of two new mechanical thrombectomy systems for the peripheral venous and arterial vasculatures, the Pounce Venous Thrombectomy System and the Pounce LP (Low Profile) Thrombectomy System during the fiscal second quarter. In January, Surmodics announced the successful ea ...